Avelumab Approved indication: Merkel cell carcinoma

被引：2
|
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2018年 / 41卷 / 02期
关键词：
D O I：
10.18773/austprescr.2018.018
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Avelumab has been approved for treatment of Merkel cell carcinoma in the US
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (05) : 968 - 968
  • [2] Extended therapeutic Spectrum Avelumab: The first drug Therapy specifically approved for Merkel Cell Carcinoma
    Walter, Monika
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11)
  • [3] Successful rechallenge with avelumab in Merkel cell carcinoma
    Amiot, Mathilde
    Possenti, Florence Brunet
    Lebbe, Celeste
    Baroudjian, Barouyr
    EUROPEAN JOURNAL OF CANCER, 2021, 153 : 96 - 97
  • [4] Avelumab for the treatment of metastatic Merkel cell carcinoma
    Cordes, L. M.
    Gulley, J. L.
    DRUGS OF TODAY, 2017, 53 (07) : 377 - 383
  • [5] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Shirley, Matt
    TARGETED ONCOLOGY, 2018, 13 (03) : 409 - 416
  • [6] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Matt Shirley
    Targeted Oncology, 2018, 13 : 409 - 416
  • [7] Immunotherapy in Merkel cell carcinoma: role of Avelumab
    Palla, Amruth R.
    Doll, Donald
    IMMUNOTARGETS AND THERAPY, 2018, 7 : 15 - 19
  • [8] Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
    Bullement, Ash
    Nathan, Paul
    Willis, Anna
    Amin, Amerah
    Lilley, Cameron
    Stapelkamp, Ceilidh
    Hatswell, Anthony
    Pescott, Chris
    Bharmal, Murtuza
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 377 - 390
  • [9] Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
    Ash Bullement
    Paul Nathan
    Anna Willis
    Amerah Amin
    Cameron Lilley
    Ceilidh Stapelkamp
    Anthony Hatswell
    Chris Pescott
    Murtuza Bharmal
    PharmacoEconomics - Open, 2019, 3 : 377 - 390
  • [10] Hyperprogression of Merkel cell carcinoma after avelumab treatment
    Pirker, R.
    Fink, A.
    Stella, A.
    Stifter, L.
    Posch, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : E675 - E677
12345